 | • レポートコード：MRC2204A194 • 出版社/出版日：Transparency Market Research / 2022年2月 • レポート形態：英文、PDF、182ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界のタウリン市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、種類別（食品用、医薬品用）分析、用途別分析、形状別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界のタウリン市場規模：種類別（食品用、医薬品用） ・世界のタウリン市場規模：用途別 ・世界のタウリン市場規模：形状別 ・世界のタウリン市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Taurine Market – Scope of Report
TMR’s report on the global taurine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall market revenue of the taurine market for the period 2017–2031, considering 2017 to 2019 as historical years, 2020 as the base year, and 2021 to 2031 as the forecast period. The report also provides the compound annual growth rate (CAGR) of the global taurine market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global taurine market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a top-down approach to study various phenomena in the global taurine market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global taurine market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global taurine market. The next section of the global taurine market report highlights the USPs, which include overview of market, regulatory scenario, COVID-19 impact, and key developments in the global taurine market.
The report delves into the competition landscape of the global taurine market. Key players operating in the global taurine market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global taurine market profiled in this report.
Key Questions Answered in Taurine Market Report
What are the major drivers, restraints, and opportunities in the global market?
What will be the revenue share projections of key segments of the global taurine market during the forecast period?
Which segment is likely to lead the global taurine market in terms of revenue by 2031?
How mergers & acquisitions among players are widening the scope of the global taurine market?
Which are the leading companies in the global taurine market?
Taurine Market – Research Objectives and Research Approach
The comprehensive report on the global taurine market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the taurine market. It is followed by market introduction, market dynamics, and an overview of the global taurine market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global taurine market. Furthermore, a Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the taurine market. The next section of the taurine market report highlights the USPs, which include technology snapshot, process overview, prominent software tools, key industry developments, regulatory scenario, and overview in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global taurine market in terms of type, application, form, and region. Key segments under each criteria have been studied at length, and the market share of each of them at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the taurine market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Taurine Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Taurine Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Qualitative Information of different applications, forms & types of taurine in Global market
5.2. Overview of Clinical Trials Data on Taurine
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and / mid / long term impact)
6. Global Taurine Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Food Grade
6.3.2. Pharmaceutical Grade
6.4. Market Attractiveness Analysis, by Type
7. Global Taurine Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Health Care Products
7.3.2. Pet Food
7.3.3. Beverage
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Taurine Market Analysis and Forecast, by Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Form, 2017–2031
8.3.1. Tablets/Capsules
8.3.2. Liquid-based Serum
8.3.3. Others
8.4. Market Attractiveness Analysis, by Form
9. Global Taurine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Taurine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Food Grade
10.2.2. Pharmaceutical Grade
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Health Care Products
10.3.2. Pet Food
10.3.3. Beverage
10.3.4. Others
10.4. Market Value Forecast, by Form, 2017–2031
10.4.1. Tablets/Capsules
10.4.2. Liquid-based Serum
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By Form
10.6.4. By Country
11. Europe Taurine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Food Grade
11.2.2. Pharmaceutical Grade
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Health Care Products
11.3.2. Pet Food
11.3.3. Beverage
11.3.4. Others
11.4. Market Value Forecast, by Form, 2017–2031
11.4.1. Tablets/Capsules
11.4.2. Liquid-based Serum
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By Form
11.6.4. By Country/Sub-region
12. Asia Pacific Taurine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Food Grade
12.2.2. Pharmaceutical Grade
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Health Care Products
12.3.2. Pet Food
12.3.3. Beverage
12.3.4. Others
12.4. Market Value Forecast, by Form, 2017–2031
12.4.1. Tablets/Capsules
12.4.2. Liquid-based Serum
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By Form
12.6.4. By Country/Sub-region
13. Latin America Taurine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Food Grade
13.2.2. Pharmaceutical Grade
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Health Care Products
13.3.2. Pet Food
13.3.3. Beverage
13.3.4. Others
13.4. Market Value Forecast, by Form, 2017–2031
13.4.1. Tablets/Capsules
13.4.2. Liquid-based Serum
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Taurine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Food Grade
14.2.2. Pharmaceutical Grade
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Health Care Products
14.3.2. Pet Food
14.3.3. Beverage
14.3.4. Others
14.4. Market Value Forecast, by Form, 2017–2031
14.4.1. Tablets/Capsules
14.4.2. Liquid-based Serum
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Taisho Pharmaceutical Holdings Co., Ltd.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Grand Pharmaceutical Group Limited
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. AWI-Awell Ingredients Co., Ltd.
15.4.3.1. Company Description
15.4.3.2. SWOT Analysis
15.4.4. The Honjo Chemical Corporation
15.4.4.1. Company Description
15.4.4.2. SWOT Analysis
15.4.5. Qianjiang Yongan Pharmaceutical Co., Ltd.
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. SWOT Analysis
15.4.6. A. B. Enterprises
15.4.6.1. Company Description
15.4.6.2. SWOT Analysis
15.4.7. Atlantic Chemicals Trading GmbH
15.4.7.1. Company Description
15.4.7.2. SWOT Analysis
15.4.8. Kyowa Hakko Bio Co., Ltd.
15.4.8.1. Company Description
15.4.8.2. SWOT Analysis
15.4.9. Jiangsu Yuanyang Pharmaceutical Co., Ltd.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd.
15.4.10.1. Company Description
15.4.10.2. SWOT Analysis
15.4.11. Advance Inorganics
15.4.11.1. Company Description
15.4.11.2. SWOT Analysis
15.4.12. Aakriti Trading Company
15.4.12.1. Company Description
15.4.12.2. SWOT Analysis
15.4.13. Avanscure Lifesciences Pvt. Ltd.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis
Table 01: Global Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 03: Global Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 04: Global Taurine Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Taurine Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 08: North America Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 09: Europe Taurine Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 12: Europe Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 13: Asia Pacific Taurine Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 16: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 17: Latin America Taurine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 20: Latin America Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 21: Middle East & Africa Taurine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 24: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031